B16.0 Acute hepatitis B with delta-agent with hepatic coma

Name of the Condition

• Acute hepatitis B with delta-agent with hepatic coma

Summary

Acute hepatitis B with delta-agent with hepatic coma is a severe viral infection characterized by liver inflammation, caused by the hepatitis B virus (HBV) and the delta agent (HDV), leading to hepatic coma. This condition involves acute liver failure and impaired consciousness due to severe liver dysfunction. The delta agent requires HBV for replication, and its presence often results in more aggressive disease progression.

Causes

Acute hepatitis B with delta-agent with hepatic coma is caused by co-infection with the hepatitis B virus (HBV) and the delta agent (HDV). The delta agent is a defective virus that requires HBV to replicate. Transmission occurs through contact with infectious blood or bodily fluids, including unprotected sexual contact, sharing needles, or perinatal exposure. The combination of HBV and HDV accelerates liver damage, increasing the risk of hepatic coma.

Risk Factors

• Co-infection with hepatitis B and delta agents
• Intravenous drug use with shared needles
• Unprotected sexual contact with an infected person
• Occupational exposure to blood (e.g., healthcare workers)
• Living in regions with high HBV/HDV prevalence
• Perinatal transmission from an infected mother

Symptoms

• Severe fatigue and malaise
• Jaundice (yellowing of the skin and eyes)
• Abdominal pain and tenderness
• Nausea, vomiting, and loss of appetite
• Dark urine or clay-colored stools
• Hepatic coma (loss of consciousness due to liver failure)
• Confusion or altered mental status

Diagnosis

Diagnosis involves blood tests to detect HBV and HDV antigens/antibodies, liver function tests to assess damage, and imaging or clinical evaluation for hepatic coma. A physical examination may reveal liver enlargement or tenderness. Additional tests, such as viral load measurements or liver biopsy, may be used to confirm severity.

Treatment Options

Treatment focuses on supportive care, including rest, hydration, and nutritional support. Antiviral medications may be used to target HBV, though HDV-specific treatments are limited. In severe cases, liver transplantation may be necessary. Management of hepatic coma involves addressing underlying liver failure and preventing complications.

Prognosis and Follow-Up

Prognosis is poor due to the severity of liver failure and hepatic coma. Recovery depends on early intervention and the extent of liver damage. Follow-up includes regular monitoring of liver function, viral load, and mental status. Long-term care may involve managing chronic liver disease or transplant-related complications.

Complications

• Acute liver failure
• Hepatic encephalopathy (progression to coma)
• Chronic hepatitis B or delta infection
• Liver cirrhosis
• Liver cancer (hepatocellular carcinoma)
• Multi-organ failure

Lifestyle & Prevention

• Avoid sharing needles or personal items that may contact blood
• Practice safe sex with barrier protection
• Ensure vaccination against hepatitis B (does not protect against HDV)
• Avoid alcohol and hepatotoxic substances
• Maintain good hygiene to reduce infection risk
• Seek prenatal care to prevent perinatal transmission

When to Seek Professional Help

Seek immediate medical attention for symptoms of hepatic coma, such as confusion, loss of consciousness, or severe jaundice. Prompt evaluation is critical for managing acute liver failure and preventing fatal outcomes.

Tips for Medical Coders

Document the presence of both hepatitis B virus and delta agent, as well as hepatic coma, to accurately assign code B16.0. Ensure clinical notes specify the delta-agent co-infection and hepatic coma to support coding. Differentiate from other acute hepatitis B codes by confirming the absence of delta-agent or hepatic coma when applicable.